FIC Capital’s Standard BioTools LAB Stock Holding History

FIC Capital’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$951K	Hold	188,700	–	–	0.36%	65
2017 Q2	$762K	Hold	188,700	–	–	0.31%	73
2017 Q1	$1.07M	Hold	188,700	–	–	0.48%	60
2016 Q4	$1.37M	Hold	188,700	–	–	0.69%	47
2016 Q3	$1.51M	Hold	188,700	–	–	0.68%	49
2016 Q2	$1.7M	Hold	188,700	–	–	0.81%	45
2016 Q1	$1.52M	Hold	188,700	–	–	0.74%	44
2015 Q4	$2.04M	Hold	188,700	–	–	0.9%	35
2015 Q3	$1.53M	Hold	188,700	–	–	0.72%	44
2015 Q2	$4.57M	Hold	188,700	–	–	1.81%	16
2015 Q1	$7.94M	Hold	188,700	–	–	3.02%	5
2014 Q4	$6.37M	Hold	188,700	–	–	2.46%	7
2014 Q3	$4.62M	Buy	+188,700	New	+$5.31M	1.85%	11

Other funds holding LAB

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIC Capital's LAB Position: Q3 2017 in Review

FIC Capital held its Standard BioTools (LAB) position steady in Q3 2017 at 188,700 shares worth $951K. The position accounts for 0.36% of the portfolio, ranked #65.

FIC Capital first reported a position in LAB in Q3 2014 and has held it in 13 quarters since. The position peaked at $7.94M in Q1 2015. 80 funds tracked by Wall St. Rank hold LAB as of Q3 2017.

FIC Capital held 188,700 shares of Standard BioTools worth $951K as of Q3 2017.
FIC Capital left its Standard BioTools share count unchanged in Q3 2017.
Standard BioTools made up 0.36% of FIC Capital's portfolio in Q3 2017, its #65 holding.
FIC Capital first reported a position in Standard BioTools in Q3 2014 and has held it in 13 quarters since.
FIC Capital's Standard BioTools position peaked at $7.94M in Q1 2015.
80 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.